AQR Arbitrage’s CureVac CVAC Stock Holding History

AQR Arbitrage’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-991,688	Closed	-$5.35M	–	508
2025 Q3	$5.35M	Buy	991,688 +947,529	+2,146%	+$5.13M	0.14%	186
2025 Q2	$240K	Buy	+44,159	New	+$175K	0.01%	297

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AQR Arbitrage's CVAC Position: Q4 2025 in Review

AQR Arbitrage sold out of CureVac (CVAC) in Q4 2025, closing a stake of 991,688 shares — an estimated $5.35M sold.

AQR Arbitrage first reported a position in CVAC in Q2 2025 and held it in 2 quarters. The position peaked at $5.35M in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

AQR Arbitrage reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
AQR Arbitrage sold 991,688 CureVac shares in Q4 2025, an estimated $5.35M.
AQR Arbitrage first reported a position in CureVac in Q2 2025 and held it in 2 quarters.
AQR Arbitrage's CureVac position peaked at $5.35M in Q3 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on AQR Arbitrage's 13F filing for Q4 2025, filed 17 Feb 2026.